Global Cancer Vaccine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
Market Overview
The global Cancer Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 21.1% in the forecast period of 2020 to 2025 and will expected to reach USD 10490 million by 2025, from USD 4876.9 million in 2019.
The Cancer Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Cancer Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Cancer Vaccine market has been segmented into
Preventive vaccines
Therapeutic vaccines
By Application, Cancer Vaccine has been segmented into:
Prostate Cancer
Cervical Cancer
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Cancer Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Cancer Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Cancer Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Cancer Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Cancer Vaccine Market Share Analysis
Cancer Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Cancer Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Cancer Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Cancer Vaccine are:
Dendreon Corporation
Inovio Pharmaceuticals
NeoStem Oncology
ImmunoGen
Novartis
Among other players domestic and global, Cancer Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cancer Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Cancer Vaccine, with price, sales, revenue and global market share of Cancer Vaccine in 2018 and 2019.
Chapter 3, the Cancer Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cancer Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Cancer Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Cancer Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Cancer Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Cancer Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Preventive vaccines
1.2.3 Therapeutic vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Cancer Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Prostate Cancer
1.3.3 Cervical Cancer
1.3.4 Others
1.4 Overview of Global Cancer Vaccine Market
1.4.1 Global Cancer Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Dendreon Corporation
2.1.1 Dendreon Corporation Details
2.1.2 Dendreon Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Dendreon Corporation SWOT Analysis
2.1.4 Dendreon Corporation Product and Services
2.1.5 Dendreon Corporation Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Inovio Pharmaceuticals
2.2.1 Inovio Pharmaceuticals Details
2.2.2 Inovio Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Inovio Pharmaceuticals SWOT Analysis
2.2.4 Inovio Pharmaceuticals Product and Services
2.2.5 Inovio Pharmaceuticals Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 NeoStem Oncology
2.3.1 NeoStem Oncology Details
2.3.2 NeoStem Oncology Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 NeoStem Oncology SWOT Analysis
2.3.4 NeoStem Oncology Product and Services
2.3.5 NeoStem Oncology Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 ImmunoGen
2.4.1 ImmunoGen Details
2.4.2 ImmunoGen Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 ImmunoGen SWOT Analysis
2.4.4 ImmunoGen Product and Services
2.4.5 ImmunoGen Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Cancer Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Cancer Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Cancer Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Cancer Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Cancer Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Cancer Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Cancer Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Cancer Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Cancer Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Cancer Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Cancer Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Cancer Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Cancer Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Cancer Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Cancer Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Cancer Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Cancer Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Cancer Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Cancer Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Cancer Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Cancer Vaccine Sales and Growth Rate (2015-2020)
6.4 France Cancer Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Cancer Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Cancer Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Cancer Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Cancer Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Cancer Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Cancer Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Cancer Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Cancer Vaccine Sales and Growth Rate (2015-2020)
7.5 India Cancer Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Cancer Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Cancer Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Cancer Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Cancer Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Cancer Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Cancer Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Cancer Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Cancer Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Cancer Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Cancer Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Cancer Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Cancer Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Cancer Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Cancer Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Cancer Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Cancer Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Cancer Vaccine Price by Type (2015-2020)
11 Global Cancer Vaccine Market Segment by Application
11.1 Global Cancer Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Cancer Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Cancer Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Cancer Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Cancer Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Cancer Vaccine Market Forecast (2021-2025)
12.2.2 Europe Cancer Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Cancer Vaccine Market Forecast (2021-2025)
12.2.4 South America Cancer Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Cancer Vaccine Market Forecast (2021-2025)
12.3 Cancer Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Cancer Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Cancer Vaccine Market Share Forecast by Type (2021-2025)
12.4 Cancer Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Cancer Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Cancer Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Tables and Figures
List of Tables
Table 1. Global Cancer Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Cancer Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Cancer Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Dendreon Corporation Basic Information, Manufacturing Base and Competitors
Table 8. Dendreon Corporation Cancer Vaccine Major Business
Table 9. Dendreon Corporation Cancer Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. Dendreon Corporation SWOT Analysis
Table 11. Dendreon Corporation Cancer Vaccine Product and Services
Table 12. Dendreon Corporation Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Inovio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Inovio Pharmaceuticals Cancer Vaccine Major Business
Table 15. Inovio Pharmaceuticals Cancer Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Inovio Pharmaceuticals SWOT Analysis
Table 17. Inovio Pharmaceuticals Cancer Vaccine Product and Services
Table 18. Inovio Pharmaceuticals Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. NeoStem Oncology Basic Information, Manufacturing Base and Competitors
Table 20. NeoStem Oncology Cancer Vaccine Major Business
Table 21. NeoStem Oncology Cancer Vaccine Total Revenue (USD Million) (2017-2018)
Table 22. NeoStem Oncology SWOT Analysis
Table 23. NeoStem Oncology Cancer Vaccine Product and Services
Table 24. NeoStem Oncology Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. ImmunoGen Basic Information, Manufacturing Base and Competitors
Table 26. ImmunoGen Cancer Vaccine Major Business
Table 27. ImmunoGen Cancer Vaccine Total Revenue (USD Million) (2017-2018)
Table 28. ImmunoGen SWOT Analysis
Table 29. ImmunoGen Cancer Vaccine Product and Services
Table 30. ImmunoGen Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Novartis Basic Information, Manufacturing Base and Competitors
Table 32. Novartis Cancer Vaccine Major Business
Table 33. Novartis Cancer Vaccine Total Revenue (USD Million) (2017-2018)
Table 34. Novartis SWOT Analysis
Table 35. Novartis Cancer Vaccine Product and Services
Table 36. Novartis Cancer Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Cancer Vaccine Sales by Manufacturer (2018-2019) (MT)
Table 38. Global Cancer Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Cancer Vaccine Sales by Regions (2015-2020) (MT)
Table 40. Global Cancer Vaccine Sales Market Share by Regions (2015-2020)
Table 41. Global Cancer Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Cancer Vaccine Sales by Countries (2015-2020) (MT)
Table 43. North America Cancer Vaccine Sales Market Share by Countries (2015-2020)
Table 44. North America Cancer Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Cancer Vaccine Revenue Market Share by Countries (2015-2020)
Table 46. Europe Cancer Vaccine Sales by Countries (2015-2020) (MT)
Table 47. Europe Cancer Vaccine Sales Market Share by Countries (2015-2020)
Table 48. Europe Cancer Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Cancer Vaccine Sales by Regions (2015-2020) (MT)
Table 50. Asia-Pacific Cancer Vaccine Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Cancer Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Cancer Vaccine Sales by Countries (2015-2020) (MT)
Table 53. South America Cancer Vaccine Sales Market Share by Countries (2015-2020)
Table 54. South America Cancer Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Cancer Vaccine Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Cancer Vaccine Sales by Countries (2015-2020) (MT)
Table 57. Middle East & Africa Cancer Vaccine Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Cancer Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Cancer Vaccine Revenue Market Share by Countries (2015-2020)
Table 60. Global Cancer Vaccine Sales by Type (2015-2020) (MT)
Table 61. Global Cancer Vaccine Sales Share by Type (2015-2020)
Table 62. Global Cancer Vaccine Revenue by Type (2015-2020) (USD Million)
Table 63. Global Cancer Vaccine Revenue Share by Type (2015-2020)
Table 64. Global Cancer Vaccine Sales by Application (2015-2020) (MT)
Table 65. Global Cancer Vaccine Sales Share by Application (2015-2020)
Table 66. Global Cancer Vaccine Sales Forecast by Regions (2021-2025) (MT)
Table 67. Global Cancer Vaccine Market Share Forecast by Regions (2021-2025)
Table 68. Global Cancer Vaccine Sales Forecast by Type (2021-2025) (MT)
Table 69. Global Cancer Vaccine Market Share Forecast by Type (2021-2025)
Table 70. Global Cancer Vaccine Sales Forecast by Application (2021-2025)
Table 71. Global Cancer Vaccine Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Cancer Vaccine Picture
Figure 2. Global Sales Market Share of Cancer Vaccine by Type in 2019
Figure 3. Preventive vaccines Picture
Figure 4. Therapeutic vaccines Picture
Figure 5. Cancer Vaccine Sales Market Share by Application in 2018
Figure 6. Prostate Cancer Picture
Figure 7. Cervical Cancer Picture
Figure 8. Others Picture
Figure 9. Global Cancer Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Cancer Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Cancer Vaccine Sales Market Share by Manufacturer in 2019
Figure 30. Global Cancer Vaccine Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Cancer Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Cancer Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 35. Global Cancer Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Cancer Vaccine Revenue Market Share by Regions (2015-2020)
Figure 37. Global Cancer Vaccine Revenue Market Share by Regions in 2018
Figure 38. North America Cancer Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Europe Cancer Vaccine Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Cancer Vaccine Sales and Growth Rate (2015-2020)
Figure 41. South America Cancer Vaccine Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Cancer Vaccine Sales and Growth Rate (2015-2020)
Figure 43. North America Cancer Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Cancer Vaccine Sales Market Share by Countries (2015-2020)
Figure 45. North America Cancer Vaccine Sales Market Share by Countries in 2018
Figure 46. North America Cancer Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Cancer Vaccine Revenue Market Share by Countries in 2018
Figure 48. United States Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 49. Canada Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 50. Mexico Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 51. Europe Cancer Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Cancer Vaccine Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Cancer Vaccine Revenue Market Share by Countries in 2019
Figure 54. Germany Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 55. UK Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 56. France Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 57. Russia Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 58. Italy Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 59. Asia-Pacific Cancer Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Cancer Vaccine Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Cancer Vaccine Revenue Market Share by Regions 2019
Figure 62. China Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 63. Japan Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 64. Korea Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 65. India Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 66. Southeast Asia Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 67. South America Cancer Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Cancer Vaccine Sales Market Share by Countries in 2019
Figure 69. South America Cancer Vaccine Revenue Market Share by Countries in 2019
Figure 70. Brazil Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 71. Argentina Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 72. Middle East and Africa Cancer Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Cancer Vaccine Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Cancer Vaccine Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Cancer Vaccine Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 77. Egypt Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 78. Turkey Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 79. South Africa Cancer Vaccine Sales and Growth Rate (2015-2020) (MT)
Figure 80. Global Cancer Vaccine Sales and Growth Rate (2021-2025) (MT)
Figure 81. Global Cancer Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Cancer Vaccine Market Forecast (2021-2025) (MT)
Figure 83. Europe Sales Cancer Vaccine Market Forecast (2021-2025) (MT)
Figure 84. Asia-Pacific Sales Cancer Vaccine Market Forecast (2021-2025) (MT)
Figure 85. South America Sales Cancer Vaccine Market Forecast (2021-2025) (MT)
Figure 86. Middle East & Africa Sales Cancer Vaccine Market Forecast (2021-2025) (MT)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Dendreon Corporation
Inovio Pharmaceuticals
NeoStem Oncology
ImmunoGen
Novartis
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets